Cargando…
Role of multimodality therapy in cIIIA-N2 non–small cell lung cancer: perspective(§)
A number of promising new approaches for both local and systemic control of locally advanced non–small cell lung cancer have been examined in clinical trials, aimed at improving the patient survival. Development of better systemic therapies by adopting newer agents (such as epidermal growth factor r...
Autor principal: | Horinouchi, Hidehito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144660/ https://www.ncbi.nlm.nih.gov/pubmed/27702837 http://dx.doi.org/10.1093/jjco/hyw131 |
Ejemplares similares
-
Advances in multimodal treatment for stage IIIA-N2 non-small cell
lung cancer
por: Montemuiño Muñiz, Sara, et al.
Publicado: (2021) -
To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
por: Horinouchi, Hidehito
Publicado: (2020) -
What is the future of targeted therapy in rheumatology: biologics or small molecules?
por: Mócsai, Attila, et al.
Publicado: (2014) -
The role of occupational therapy in substance use
por: Doğu, Selma Ercan, et al.
Publicado: (2023) -
Decision-making capacity evaluations: the role of neuropsychological assessment from a multidisciplinary perspective
por: Wood, Sarah, et al.
Publicado: (2020)